Weight Loss Drugs: Hype, Hope, or Health Hazard? Unpacking the Reality in India
Weight Loss Drugs: Hype, Hope, or Health Hazard? Unpacking the Reality in India
- •Newer weight-loss drugs like Ozempic and Wegovy mimic GLP-1, slowing digestion and promoting fullness.
- •Dr. G. Moinoddin of Manipal Hospital notes growing enthusiasm in India but warns of significant side effects like nausea, vomiting, and potential thyroid malignancies.
- •These drugs are expensive, and most patients regain 80-90% of lost weight upon discontinuation.
- •Average weight loss is modest (6-10% over six months), making them suitable for mildly overweight individuals (BMI 25-30).
- •Bariatric surgery remains the gold standard for morbid obesity, offering 50-60% sustained weight loss and metabolic benefits.